Central Catheters Used for Chemotherapy in Women With Breast Cancer

• Status: Completed
• Trial end date: 2021-02-01
• Target enrollment: 0
• Participant gender: Female

Summary

The overall aim of this study is to evaluate two different central venous lines, PICC-lines (PICC) and subcutaneous venous access ports (SVAP) used for chemotherapy in women with breast cancer. The study will compare complications, material wear of the catheters used, patients'- and health care professionals' experiences, and costs. The study will give knowledge about which central venous access that is the most advantageous regarding adjuvant chemotherapy for women with breast cancer in the aspects of safety, quality of care, and quality of life.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Swedish Red Cross University College
• Collaborators: Karolinska Institutet; Karolinska University Hospital; KTH Royal Institute of Technology; Norwegian University of Science and Technology; Stockholm South General Hospital
• Treatments: Docetaxel; Paclitaxel

Criteria

Inclusion Criteria:

• adjuvant or neo adjuvant chemotherapy,

• speak Swedish

Exclusion Criteria:

• cognitive dysfunction

• and/or inability to understand Swedish,

• recurrent breast cancer